Literature DB >> 21242974

Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling.

B Cha1, W Kim, Y K Kim, B N Hwang, S Y Park, J W Yoon, W S Park, J W Cho, M T Bedford, E-h Jho.   

Abstract

Axin, a negative regulator of Wnt signaling, is a key scaffold protein for the β-catenin destruction complex. It has been previously shown that multiple post-translational modification enzymes regulate the level of Axin. Here, we provide evidence that protein arginine methyltransferase 1 (PRMT1) directly interacts with and methylates the 378th arginine residue of Axin both in vitro and in vivo. We found that the transient expression of PRMT1 led to an increased level of Axin and that knockdown of endogenous PRMT1 by short hairpin RNA reduced the level of Axin. These results suggest that methylation by PRMT1 enhanced the stability of Axin. Methylation of Axin by PRMT1 also seemingly enhanced the interaction between Axin and glycogen synthase kinase 3β, leading to decreased ubiquitination of Axin. Consistent with the role of PRMT1 in the regulation of Axin, knockdown of PRMT1 enhanced the level of cytoplasmic β-catenin as well as β-catenin-dependent transcription activity. In summary, we show that the methylation of Axin occurred in vivo and controlled the stability of Axin. Therefore, methylation of Axin by PRMT1 may serve as a finely tuned regulation mechanism for Wnt/β-catenin signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242974     DOI: 10.1038/onc.2010.610

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

Review 1.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 2.  Role of PRMTs in cancer: Could minor isoforms be leaving a mark?

Authors:  R Mitchell Baldwin; Alan Morettin; Jocelyn Côté
Journal:  World J Biol Chem       Date:  2014-05-26

3.  Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming ω-NG-monomethylated arginine residues.

Authors:  Cecilia I Zurita-Lopez; Troy Sandberg; Ryan Kelly; Steven G Clarke
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

4.  Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans.

Authors:  Soumen K Manna; Naoki Tanaka; Kristopher W Krausz; Majda Haznadar; Xiang Xue; Tsutomu Matsubara; Elise D Bowman; Eric R Fearon; Curtis C Harris; Yatrik M Shah; Frank J Gonzalez
Journal:  Gastroenterology       Date:  2014-01-15       Impact factor: 22.682

5.  Liver disease-associated keratin 8 and 18 mutations modulate keratin acetylation and methylation.

Authors:  Kwi-Hoon Jang; Han-Na Yoon; Jongeun Lee; Hayan Yi; Sang-Yoon Park; So-Young Lee; Younglan Lim; Hyoung-Joo Lee; Jin-Won Cho; Young-Ki Paik; Williams S Hancock; Nam-On Ku
Journal:  FASEB J       Date:  2019-06-14       Impact factor: 5.191

Review 6.  Protein arginine methyltransferases and cancer.

Authors:  Yanzhong Yang; Mark T Bedford
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

7.  Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis.

Authors:  Y Gou; J Li; O Jackson-Weaver; J Wu; T Zhang; R Gupta; I Cho; T V Ho; Y Chen; M Li; S Richard; J Wang; Y Chai; J Xu
Journal:  J Dent Res       Date:  2018-07-09       Impact factor: 6.116

8.  Regulating the response to targeted MEK inhibition in melanoma: enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation.

Authors:  William H Conrad; Reyna D Swift; Travis L Biechele; Rima M Kulikauskas; Randall T Moon; Andy J Chien
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 9.  Histone methylation modifiers in cellular signaling pathways.

Authors:  Hunain Alam; Bingnan Gu; Min Gyu Lee
Journal:  Cell Mol Life Sci       Date:  2015-08-25       Impact factor: 9.261

10.  Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells.

Authors:  R Mitchell Baldwin; Alan Morettin; Genevieve Paris; Isabelle Goulet; Jocelyn Côté
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.